Evidence map›Paper›PMID 31928630›Full record

ArticleeLife2020

Cytomegalovirus protein m154 perturbs the adaptor protein-1 compartment mediating broad-spectrum immune evasion.

Ivana Strazic Geljic, Paola Kucan Brlic, Guillem Angulo, Ilija Brizic, Berislav Lisnic, Tina Jenus, Vanda Juranic Lisnic, Gian Pietro Pietri, Pablo Engel, Noa Kaynan and 7 more

Abstract read
In one paragraph

Article in eLife, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Virus infection and vesicle trafficking.Frontiers in immunology · 2025
    Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Ivana Strazic Geljic *Center for Proteomics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.ORCID 0000-0001-9394-493X
Paola Kucan Brlic *Center for Proteomics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.ORCID 0000-0002-9178-9128
Guillem AnguloImmunology Unit, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.
Ilija BrizicCenter for Proteomics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.
Berislav LisnicCenter for Proteomics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.
Tina JenusCenter for Proteomics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.
Vanda Juranic LisnicCenter for Proteomics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.
Gian Pietro PietriCenter for Proteomics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.
Pablo EngelImmunology Unit, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.
Noa KaynanThe Lautenberg Center for General and Tumor Immunology, The BioMedical Research Institute, Hadassah Medical School, The Hebrew University, Jerusalem, Israel.
Jelena ZeleznjakCenter for Proteomics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.
Peter SchuZentrum für Biochemie und Molekulare Zellbiologie Institut für Zellbiochemie, Georg-August-Universität Göttingen, Goettingen, Germany.
Ofer MandelboimThe Lautenberg Center for General and Tumor Immunology, The BioMedical Research Institute, Hadassah Medical School, The Hebrew University, Jerusalem, Israel.ORCID 0000-0002-9354-1855
Astrid KrmpoticDepartment of Histology and Embryology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.
Ana AnguloImmunology Unit, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.
Stipan JonjicCenter for Proteomics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.
Tihana Lenac RovisCenter for Proteomics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.ORCID 0000-0002-3299-1334

Funding

European Regional Development Fund KK.01.1.1.01.0006Hrvatska Zaklada za Znanost UIP-11-2013-1533Ministerio de Economía y Competitividad SAF2017-87688
6 · The paper itself

Abstract

Cytomegaloviruses (CMVs) are ubiquitous pathogens known to employ numerous immunoevasive strategies that significantly impair the ability of the immune system to eliminate the infected cells. Here, we report that the single mouse CMV (MCMV) protein, m154, downregulates multiple surface molecules involved in the activation and costimulation of the immune cells. We demonstrate that m154 uses its cytoplasmic tail motif, DD, to interfere with the adaptor protein-1 (AP-1) complex, implicated in intracellular protein sorting and packaging. As a consequence of the perturbed AP-1 sorting, m154 promotes lysosomal degradation of several proteins involved in T cell costimulation, thus impairing virus-specific CD8

Indexed as

Adaptor Protein Complex 1AnimalsCell LineDown-RegulationHumansImmune EvasionMembrane ProteinsMice, Inbred BALB CMice, Inbred C57BLMuromegalovirusViral ProteinsAdaptor Protein Complex 1Membrane ProteinsViral Proteinsadaptor protein-1, AP-1CD8+ T cellscytomegalovirus, CMVimmune evasionimmunologyinfectious diseaseinflammationm154 proteinmicrobiologyPVR, CD155virus

Identifiers

PMID31928630
PMCPMC6957316

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.